GAS5 and neoplasm: In contrast to IL-2-activated NK cells, which show high expression of lncRNA GAS5 and intense IFN-γ release, lncRNA GAS5 is downregulated in liver cancer patient-derived NK cells, contributing to reduced NK-mediated cytotoxicity and tumor immune-escape.